Vulvovaginal Candidiasis - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Vulvovaginal Candidiasis -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Vulvovaginal Candidiasis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Vulvovaginal Candidiasis. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Vulvovaginal Candidiasis. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Vulvovaginal Candidiasis sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Vulvovaginal Candidiasis market.

  • Identifying prevalent patient populations as well as risk factors in the global Vulvovaginal Candidiasis market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Vulvovaginal Candidiasis therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Vulvovaginal Candidiasis - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Vulvovaginal Candidiasis Overview
Vulvovaginal Candidiasis Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Vulvovaginal Candidiasis

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Vulvovaginal Candidiasis
Sex-Specific Prevalent/Incident Cases of Vulvovaginal Candidiasis
Disease Type Specific Prevalent/Incident Cases of Vulvovaginal Candidiasis

8.Prevalent & Incident Cases by 7 MM-2015-2025
Vulvovaginal Candidiasis Epidemiology of United States-2025
Vulvovaginal Candidiasis Epidemiology of United Kingdom-2025
Vulvovaginal Candidiasis Epidemiology of Germany-2025
Vulvovaginal Candidiasis Epidemiology of France-2025
Vulvovaginal Candidiasis Epidemiology of Spain-2025
Vulvovaginal Candidiasis Epidemiology of Italy-2025
Vulvovaginal Candidiasis Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Vulvovaginal Candidiasis Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Vulvovaginal Candidiasis Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Vulvovaginal Candidiasis Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Vulvovaginal Candidiasis (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Vulvovaginal Candidiasis By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Vulvovaginal Candidiasis Sub-population,Japan (2015-2025)
  • Global and Regional Postmenopausal Vaginal Atrophy Treatment Market Research Report 2017
    Published: 09-Dec-2017        Price: US 3500 Onwards        Pages: 128
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. Market Segment as follows: By Region - Asia-Pacific......
  • China Contraceptives Market Research Report 2017
    Published: 05-Dec-2017        Price: US 3400 Onwards        Pages: 107
    The global Contraceptives market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Contraceptives development status and future trend in China, focuses on top players in China, also splits Contraceptives b......
  • Global Contraceptives Market Professional Survey Report 2017
    Published: 24-Nov-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Contraceptives in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Merck - Cipla Inc. - Allergan plc - Bayer AG - HLL Lifecare Li......
  • Global Topical Contraceptive Market Professional Survey Report 2017
    Published: 22-Nov-2017        Price: US 3500 Onwards        Pages: 128
    This report studies Topical Contraceptive in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - Merck Millipore - Allergan - Mylan - Teva Phar......
  • 2017-2022 China Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 20-Nov-2017        Price: US 3360 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include - Bayer - Pfizer - Sanofi - Piramal - Abbott - Galderma - Mission - Alkem - Xiuzheng - Teva - Perrigo......
  • 2017-2022 Europe Top Countries Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4660 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Bacterial Vaginosis Drug market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering......
  • 2017-2022 Global Top Countries Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4960 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Bacterial Vaginosis Drug market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle E......
  • 2017-2022 India Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 20-Nov-2017        Price: US 3360 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include - Bayer - Pfizer - Sanofi - Piramal - Abbott - Galderma - Mission - Alkem - Xiuzheng - Teva - P......
  • 2017-2022 North America Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4660 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Bacterial Vaginosis Drug market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering - Bayer - Pfizer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs